JP2008515782A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515782A5 JP2008515782A5 JP2007531877A JP2007531877A JP2008515782A5 JP 2008515782 A5 JP2008515782 A5 JP 2008515782A5 JP 2007531877 A JP2007531877 A JP 2007531877A JP 2007531877 A JP2007531877 A JP 2007531877A JP 2008515782 A5 JP2008515782 A5 JP 2008515782A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- optionally substituted
- chain
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 31
- 125000000623 heterocyclic group Chemical group 0.000 claims 19
- 125000003118 aryl group Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 125000000539 amino acid group Chemical group 0.000 claims 11
- 125000005842 heteroatom Chemical group 0.000 claims 10
- 125000000524 functional group Chemical group 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 150000001412 amines Chemical group 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 claims 5
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims 4
- 235000008206 alpha-amino acids Nutrition 0.000 claims 4
- 230000036436 anti-hiv Effects 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 150000001576 beta-amino acids Chemical class 0.000 claims 4
- -1 carbocycle Chemical group 0.000 claims 4
- 150000003857 carboxamides Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 3
- 208000031886 HIV Infections Diseases 0.000 claims 3
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 claims 3
- 208000037357 HIV infectious disease Diseases 0.000 claims 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- 229910004013 NO 2 Inorganic materials 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000002877 alkyl aryl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 235000009582 asparagine Nutrition 0.000 claims 3
- 229960001230 asparagine Drugs 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 3
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000004419 alkynylene group Chemical group 0.000 claims 2
- 125000000732 arylene group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 229910014033 C-OH Inorganic materials 0.000 claims 1
- 229910014570 C—OH Inorganic materials 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 150000002923 oximes Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 238000009118 salvage therapy Methods 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 0 CC(C(C1*)=*)=C(*)c2c1[n](*)c(*)c2P(*)(*)=N Chemical compound CC(C(C1*)=*)=C(*)c2c1[n](*)c(*)c2P(*)(*)=N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61106104P | 2004-09-17 | 2004-09-17 | |
| US60/611,061 | 2004-09-17 | ||
| US71144505P | 2005-08-25 | 2005-08-25 | |
| US60/711,445 | 2005-08-25 | ||
| US71156505P | 2005-08-26 | 2005-08-26 | |
| US60/711,565 | 2005-08-26 | ||
| PCT/IB2005/004063 WO2006054182A2 (en) | 2004-09-16 | 2005-09-16 | Phosphoindoles as hiv inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008515782A JP2008515782A (ja) | 2008-05-15 |
| JP2008515782A5 true JP2008515782A5 (https=) | 2008-11-06 |
| JP5031569B2 JP5031569B2 (ja) | 2012-09-19 |
Family
ID=36407947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531877A Expired - Fee Related JP5031569B2 (ja) | 2004-09-17 | 2005-09-16 | Ｈｉｖ阻害剤としてのホスホインドール |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7534809B2 (https=) |
| EP (3) | EP2256124A1 (https=) |
| JP (1) | JP5031569B2 (https=) |
| KR (1) | KR101242962B1 (https=) |
| CN (1) | CN102304150B (https=) |
| AT (2) | ATE479693T1 (https=) |
| AU (1) | AU2005305609B2 (https=) |
| BR (1) | BRPI0515344A (https=) |
| CA (1) | CA2583409C (https=) |
| CY (1) | CY1109440T1 (https=) |
| DE (2) | DE602005011031D1 (https=) |
| DK (1) | DK1799696T3 (https=) |
| ES (1) | ES2320252T3 (https=) |
| HR (1) | HRP20090086T3 (https=) |
| IL (1) | IL181909A0 (https=) |
| MX (1) | MX2007003040A (https=) |
| NO (1) | NO20071871L (https=) |
| NZ (1) | NZ554232A (https=) |
| PL (1) | PL1799696T3 (https=) |
| PT (1) | PT1799696E (https=) |
| RS (1) | RS50981B (https=) |
| SG (1) | SG155939A1 (https=) |
| SI (1) | SI1799696T1 (https=) |
| WO (1) | WO2006054182A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005011031D1 (en) | 2004-09-17 | 2008-12-24 | Idenix Pharmaceuticals Inc | Phosphoindole als hiv-inhibitoren |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
| US20100113421A1 (en) * | 2006-10-06 | 2010-05-06 | Williams Theresa M | Non-nucleoside reverse transcriptase inhibitors |
| BRPI0811645A2 (pt) | 2007-05-30 | 2014-11-11 | Hoffmann La Roche | Inibidores de transcriptase reversa de não-nucleosídeo |
| TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
| TW200944537A (en) * | 2008-04-03 | 2009-11-01 | Idenix Pharmaceuticals Inc | Formulations comprising a phosphoindole compound and one or more second active agents |
| EP2393822B1 (en) * | 2009-02-03 | 2014-07-16 | IDENIX Pharmaceuticals, Inc. | Phosphinate ruthenium complexes |
| EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| PE20121524A1 (es) | 2010-01-27 | 2012-12-03 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos |
| CN103275126B (zh) * | 2013-05-28 | 2016-03-23 | 兰州大学 | 一种立体选择性合成3-位膦酰化吲哚的方法 |
| ITMI20131218A1 (it) * | 2013-07-19 | 2015-01-20 | Need Pharma Srl | Nuovi ureido derivati di acidi naftalensolfonici |
| CA3079140A1 (en) * | 2017-10-13 | 2019-04-18 | Ursure, Inc. | Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4866084A (en) | 1987-07-17 | 1989-09-12 | Harbor Branch Oceanographic Institution, Inc. | Topsentin compounds effective against viruses and certain tumors |
| US5124327A (en) * | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
| US5527819A (en) * | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| DE4217964A1 (de) * | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
| HUT74614A (en) | 1993-02-24 | 1997-01-28 | Merck & Co Inc | Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them |
| US5424329A (en) | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
| US5612330A (en) | 1994-03-07 | 1997-03-18 | Warner-Lambert Company | Methods for inhibiting and controlling viral growth |
| US5489586A (en) * | 1994-03-07 | 1996-02-06 | Warner-Lambert Company | Method for treating inflammatory disease in humans |
| US5489685A (en) * | 1994-05-12 | 1996-02-06 | Merck & Co., Ltd. | Method of synthesizing furo[2,3-b]pyridine carboxylic acid esters |
| US5852011A (en) | 1994-05-31 | 1998-12-22 | Mitsui Chemicals, Inc. | Benzimidazole derivatives |
| US5734081A (en) * | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
| US5981525A (en) * | 1995-01-10 | 1999-11-09 | Smithkline Beecham Corporation | Indole derivatives useful in the treatment of osteoporosis |
| US6011021A (en) | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| US6046180A (en) * | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US6017903A (en) * | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US6025345A (en) * | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US6025344A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| GB9614347D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
| PL332413A1 (en) | 1996-09-27 | 1999-09-13 | Guilford Pharm Inc | Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals |
| US5830894A (en) * | 1997-02-21 | 1998-11-03 | Viropharma Incorporated | Methods for preventing and treating pestivirus infection and associated diseases |
| US5935982A (en) | 1997-02-28 | 1999-08-10 | The University Of North Carolina At Chapel Hill | Methods of treating retroviral infection and compounds useful therefor |
| US6068988A (en) | 1997-02-28 | 2000-05-30 | Biosynth Ag | Detection of microbial metabolites with a 3-indoxyl-myo-inositol-1-phosphate compound |
| EP0994707A4 (en) * | 1997-05-27 | 2001-11-14 | Guilford Pharm Inc | INHIBITORS OF NAALADASE ENZYME ACTIVITY |
| PL343249A1 (en) | 1998-03-26 | 2001-07-30 | Shionogi & Co | Indole derivatives with antiviral activity |
| IT1299068B1 (it) | 1998-04-10 | 2000-02-07 | Chemi Spa | Legandi fosforati chirali e loro complessi organometallici, utili come catalizzatori in sintesi stereoselettive |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| WO2002083126A1 (en) * | 2001-04-11 | 2002-10-24 | Idenix (Cayman) Limited | Phenylindoles for the treatment of hiv |
| US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| JP3368273B1 (ja) * | 2001-12-28 | 2003-01-20 | 株式会社トミー | 動作玩具の駆動装置及び動作玩具 |
| US20030236277A1 (en) * | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| AU2003231765B9 (en) * | 2002-04-26 | 2010-01-28 | Gilead Sciences, Inc. | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| US6900206B2 (en) * | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| US20040063746A1 (en) * | 2002-07-25 | 2004-04-01 | Alicia Regueiro-Ren | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| AU2003258145A1 (en) | 2002-08-07 | 2004-02-25 | Idenix (Cayman) Limited | Substituted phenylindoles for the treatment of hiv |
| DE602005011031D1 (en) | 2004-09-17 | 2008-12-24 | Idenix Pharmaceuticals Inc | Phosphoindole als hiv-inhibitoren |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
-
2005
- 2005-09-16 DE DE602005011031T patent/DE602005011031D1/de not_active Expired - Lifetime
- 2005-09-16 SG SG200906239-9A patent/SG155939A1/en unknown
- 2005-09-16 HR HR20090086T patent/HRP20090086T3/xx unknown
- 2005-09-16 EP EP10174740A patent/EP2256124A1/en not_active Withdrawn
- 2005-09-16 KR KR1020077008493A patent/KR101242962B1/ko not_active Expired - Fee Related
- 2005-09-16 CN CN201110185299.9A patent/CN102304150B/zh not_active Expired - Fee Related
- 2005-09-16 AT AT08075531T patent/ATE479693T1/de not_active IP Right Cessation
- 2005-09-16 PL PL05850774T patent/PL1799696T3/pl unknown
- 2005-09-16 JP JP2007531877A patent/JP5031569B2/ja not_active Expired - Fee Related
- 2005-09-16 PT PT05850774T patent/PT1799696E/pt unknown
- 2005-09-16 DK DK05850774T patent/DK1799696T3/da active
- 2005-09-16 WO PCT/IB2005/004063 patent/WO2006054182A2/en not_active Ceased
- 2005-09-16 DE DE602005023360T patent/DE602005023360D1/de not_active Expired - Lifetime
- 2005-09-16 AT AT05850774T patent/ATE414092T1/de active
- 2005-09-16 NZ NZ554232A patent/NZ554232A/en not_active IP Right Cessation
- 2005-09-16 ES ES05850774T patent/ES2320252T3/es not_active Expired - Lifetime
- 2005-09-16 EP EP08075531A patent/EP1961757B1/en not_active Expired - Lifetime
- 2005-09-16 RS RSP-2009/0057A patent/RS50981B/sr unknown
- 2005-09-16 MX MX2007003040A patent/MX2007003040A/es active IP Right Grant
- 2005-09-16 SI SI200530547T patent/SI1799696T1/sl unknown
- 2005-09-16 BR BRPI0515344-1A patent/BRPI0515344A/pt not_active IP Right Cessation
- 2005-09-16 CA CA2583409A patent/CA2583409C/en not_active Expired - Fee Related
- 2005-09-16 AU AU2005305609A patent/AU2005305609B2/en not_active Ceased
- 2005-09-16 US US11/229,150 patent/US7534809B2/en active Active
- 2005-09-16 EP EP05850774A patent/EP1799696B1/en not_active Expired - Lifetime
-
2007
- 2007-03-13 IL IL181909A patent/IL181909A0/en unknown
- 2007-04-12 NO NO20071871A patent/NO20071871L/no not_active Application Discontinuation
-
2008
- 2008-11-21 US US12/275,510 patent/US8044091B2/en not_active Expired - Lifetime
-
2009
- 2009-02-04 CY CY20091100127T patent/CY1109440T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515782A5 (https=) | ||
| ES2605152T3 (es) | Derivados de pirazolquinolinona, su preparación y su uso terapéutico | |
| JP2021526133A5 (https=) | ||
| JP2009507036A5 (https=) | ||
| JP2009504763A5 (https=) | ||
| CA2536136A1 (en) | Aryloxy and arylalkyleneoxy substituted imidazoquinolines | |
| EP2457918A3 (en) | Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | |
| JP2007502804A5 (https=) | ||
| AR059425A1 (es) | Amidas ciclicas condensadas del acido bencensulfonico, un metodo para su preparacion, composiciones farmaceuticas que las contienen y el empleo de las mismas en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de l-cpt1 | |
| JP2012509846A5 (https=) | ||
| JP2007513170A5 (https=) | ||
| JP2008509166A5 (https=) | ||
| JP2008530099A5 (https=) | ||
| EA013207B1 (ru) | Ингибиторы вирусной полимеразы | |
| ATE517908T1 (de) | Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände | |
| JP2022095872A5 (https=) | ||
| RU2008119842A (ru) | Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1 | |
| RU2005137032A (ru) | Применение оксазолидинон-хинолиновых гибридных антибиотиков для лечения сибирской язвы и других инфекций | |
| JP2005533789A5 (https=) | ||
| ATE473221T1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus | |
| JP2017531689A5 (https=) | ||
| JP2018529648A5 (https=) | ||
| JP2011506566A5 (https=) | ||
| JP2007500222A5 (https=) | ||
| JOP20240217A1 (ar) | مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة |